A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary…

By D. Hasdai, S. Behar, L. Wallentin, N. Danchin, Anselm K. Gitt, E. Boersma, P. Fioretti, M. Simoons, A. Battler. European Heart Journal, 2002

822 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/1cc62b0905a01f101a5ae15158e87cbcb255beb1

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Ralph B. D’Agostino
2. Michael J. Pencina
3. Gerasimos Filippatos
4. A. Vahanian

In Radiology, Nuclear Medicine and Imaging

1. Ralph B. D’Agostino
2. Erling Falk

Citations in the corpus

• One-year cardiovascular event rates in outpatients with atherothrombosis. (2007, result): “These data complement other large-scale global data sets designed to explore the epidemiology(25,26) or acute management of patients with atherothrombosis.(27-34) Despite the size, scope, and quality of the REACH data set, this analysis has several limitations.”
• A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. (2003, background): “Previous surveys have been conducted in the field of prevention, heart failure and acute coronary syndromes.(2,3)”
• The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. (2004, neutral): “Medication b-Blockers 795 (38) 2006 (70) ACE-inhibitors or ARBs 961 (46) 1729 (61) Calcium antagonists 509 (24) 802 (28) Diuretics 541 (26) 958 (34) Lipid-lowering drugs 735 (35) 1933 (68) ASA 926 (44) 2062 (72) Clopidogrel or Ticlopidine 183 (9) 448 (16)”
• Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. (2003, background): “4% at 1 month.(13) The WHO-MONICA investigators convincingly demonstrated that, also at the population level, the introduction of new treatments for coronary care was strongly linked with declining coronary event rates and 28-day case fatality.”
• The second Euro Heart Survey on acute coronary syndromes: Characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. (2006, methodology): “Each participating centre was also asked to complete a questionnaire, designed to provide a description of the medical centre.(9) Electronic case report forms were used for data entry and transferred via the web to a central database located in the European Heart House, where they were edited for mi”